FDA 483 - Fresenius Kabi USA LLC - June 30, 2022
FDA 483 for Fresenius Kabi USA LLC on June 30, 2022. Product: drugs. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for Fresenius Kabi USA LLC on June 30, 2022. Product: drugs. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Fresenius Kabi USA LLCInspection Date
June 30, 2022
Product Type
drugs
ID: ebb22448-70a3-47c3-a8d6-b79a23abfb6b
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox